Bone Marrow Mesenchymal Stem Cell Donors with a High Body Mass Index Display Elevated Endoplasmic Reticulum Stress and are Functionally Impaired
Göster/ Aç
Tarih
2018Yazar
Ulum, Baris
Teker, H Taner
Sarikaya, Aysun
Balta, Gunay
Kuskonmaz, Baris
Uckan Cetinkaya, Duygu
Aerts Kaya, Fatma
Üst veri
Tüm öğe kaydını gösterÖzet
Bone marrow mesenchymal stem cells (BM‐MSCs) are promising candidates for
regenerative medicine purposes. The effect of obesity on the function of BM‐MSCs is
currently unknown. Here, we assessed how obesity affects the function of BM‐MSCs and
the role of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR)
therein. BM‐MSCs were obtained from healthy donors with a normal (<25) or high (>30)
body mass index (BMI). High‐BMI BM‐MSCs displayed severely impaired osteogenic and
diminished adipogenic differentiation, decreased proliferation rates, increased senescence, and elevated expression of ER stress–related genes ATF4 and CHOP. Suppression
of ER stress using tauroursodeoxycholic acid (TUDCA) and 4‐phenylbutyrate (4‐PBA)
resulted in partial recovery of osteogenic differentiation capacity, with a significant
increase in the expression of ALPL and improvement in the UPR. These data indicate that
BMI is important during the selection of BM‐MSC donors for regenerative medicine
purposes and that application of high‐BMI BM‐MSCs with TUDCA or 4‐PBA may
improve stem cell function. However, whether this improvement can be translated into
an in vivo clinical advantage remains to be assessed.